Skip to main content
Top
Published in: BMC Neurology 1/2024

Open Access 01-12-2024 | Neuromyelitis Optica Spectrum Disease | Research

T1 hypointense brain lesions in NMOSD and its relevance with disability: a single institution cross-sectional study

Authors: Mohamad Ghazanfari Hashemi, Vahid Talebi, Naghmeh Abbasi Kasbi, Mehrshad Abbasi, Nasrin Asgari, Mohammad Ali Sahraian

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Background

T1 hypointense lesions are considered a surrogate marker of tissue destruction. Although there is a shortage of evidence about T1 hypointense brain lesions, black holes, in patients with Neuromyelitis Optica Spectrum Disorder (NMOSD), the clinical significance of these lesions is not well determined.

Objectives

The impact of T1 hypointense brain lesions on the clinical status and the disability level of patients with NMOSD was sought in this study.

Methods

A total of 83 patients with the final diagnosis of NMOSD were recruited.
Aquaporin-4 measures were collected. The expanded disability status scale (EDSS) and MRI studies were also extracted.
T1 hypointense and T2/FLAIR hyperintense lesions were investigated. The correlation of MRI findings, AQP-4, and EDSS was assessed.

Results

T1 hypointense brain lesions were detected in 22 patients. Mean ± SD EDSS was 3.7 ± 1.5 and significantly higher in patients with brain T1 hypointense lesions than those without them (p-value = 0.01). Noticeably, patients with more than four T1 hypointense lesions had EDSS scores ≥ 4. The presence of T2/FLAIR hyperintense brain lesions correlated with EDSS (3.6 ± 1.6 vs 2.3 ± 1.7; p-value = 0.01). EDSS was similar between those with and without positive AQP-4 (2.7 ± 1.6 vs. 3.2 ± 1.7; p-value = 0.17). Also, positive AQP-4 was not more prevalent in patients with T1 hypointense brain lesions than those without them (50.9 vs 45.4%; p-value = 0.8).

Conclusion

We demonstrated that the presence of the brain T1-hypointense lesions corresponds to a higher disability level in NMOSD.
Literature
1.
go back to reference Paul S, Mondal GP, Bhattacharyya R, Ghosh KC, Bhat IA. Neuromyelitis optica spectrum disorders. J Neurol Sci. 2021;15:420. Paul S, Mondal GP, Bhattacharyya R, Ghosh KC, Bhat IA. Neuromyelitis optica spectrum disorders. J Neurol Sci. 2021;15:420.
2.
go back to reference Eskandarieh S, Nedjat S, Abdollahpour I, Moghadasi AN, Azimi AR, Sahraian MA. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study. Mult Scler Relat Disord. 2017;1(12):39–43.CrossRef Eskandarieh S, Nedjat S, Abdollahpour I, Moghadasi AN, Azimi AR, Sahraian MA. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study. Mult Scler Relat Disord. 2017;1(12):39–43.CrossRef
3.
go back to reference Rafiee F, Tarjoman T, Moghadasi AN, Sahraian MA, Azimi A, Rezaeimanesh N, et al. Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study. Mult Scler Relat Disord. 2020;1:46. Rafiee F, Tarjoman T, Moghadasi AN, Sahraian MA, Azimi A, Rezaeimanesh N, et al. Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study. Mult Scler Relat Disord. 2020;1:46.
4.
go back to reference Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015;84(11):1165–73.CrossRefPubMedPubMedCentral Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015;84(11):1165–73.CrossRefPubMedPubMedCentral
5.
go back to reference Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89.CrossRefPubMedPubMedCentral Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89.CrossRefPubMedPubMedCentral
6.
go back to reference Chan KH, Tse CT, Chung CP, Lee RLC, Kwan JSC, Ho PWL, et al. Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol. 2011;68(11):1432–9.CrossRefPubMed Chan KH, Tse CT, Chung CP, Lee RLC, Kwan JSC, Ho PWL, et al. Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol. 2011;68(11):1432–9.CrossRefPubMed
7.
go back to reference Kim W, Park MS, Lee SH, Kim SH, Jung IJ, Takahashi T, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin4 autoimmunity. Mult Scler. 2010;16(10):1229–36.CrossRefPubMed Kim W, Park MS, Lee SH, Kim SH, Jung IJ, Takahashi T, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin4 autoimmunity. Mult Scler. 2010;16(10):1229–36.CrossRefPubMed
8.
go back to reference Bichuetti DB, Rivero RLM, Oliveira DM, De Souza NA, Abdala N, Oliveira EML, et al. Neuromyelitis optica: brain abnormalities in a Brazilian cohort. Arq Neuropsiquiatr. 2008;66(1):1–4.CrossRefPubMed Bichuetti DB, Rivero RLM, Oliveira DM, De Souza NA, Abdala N, Oliveira EML, et al. Neuromyelitis optica: brain abnormalities in a Brazilian cohort. Arq Neuropsiquiatr. 2008;66(1):1–4.CrossRefPubMed
9.
go back to reference Cassinotto C, Deramond H, Olindo S, Aveillan M, Smadja D, Cabre P. MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis. J Neuroradiol. 2009;36(4):199–205.CrossRefPubMed Cassinotto C, Deramond H, Olindo S, Aveillan M, Smadja D, Cabre P. MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis. J Neuroradiol. 2009;36(4):199–205.CrossRefPubMed
10.
go back to reference Huh SY, Min JH, Kim W, Kim SH, Kim HJ, Kim BJ, et al. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler. 2014;20(6):695–704.CrossRefPubMed Huh SY, Min JH, Kim W, Kim SH, Kim HJ, Kim BJ, et al. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler. 2014;20(6):695–704.CrossRefPubMed
11.
go back to reference Rocca MA, Comi G, Filippi M. The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis. Front Neurol. 2017;8:433.CrossRefPubMedPubMedCentral Rocca MA, Comi G, Filippi M. The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis. Front Neurol. 2017;8:433.CrossRefPubMedPubMedCentral
12.
go back to reference Akaishi T, Takahashi T, Fujihara K, Misu T, Mugikura S, Abe M, et al. Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis. PLoS One. 2020;15(4):e0231225.CrossRefPubMedPubMedCentral Akaishi T, Takahashi T, Fujihara K, Misu T, Mugikura S, Abe M, et al. Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis. PLoS One. 2020;15(4):e0231225.CrossRefPubMedPubMedCentral
13.
go back to reference Makino T, Ito S, Mori M, Yonezu T, Ogawa Y, Kuwabara S. Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica. Mult Scler. 2013;19(3):308–15.CrossRefPubMed Makino T, Ito S, Mori M, Yonezu T, Ogawa Y, Kuwabara S. Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica. Mult Scler. 2013;19(3):308–15.CrossRefPubMed
14.
go back to reference Cao G, Duan Y, Zhang N, Sun J, Li H, Li Y, et al. Brain MRI characteristics in neuromyelitis optica spectrum disorders: A large multi-center retrospective study in China. Mult Scler Relat Disord. 2020;1:46. Cao G, Duan Y, Zhang N, Sun J, Li H, Li Y, et al. Brain MRI characteristics in neuromyelitis optica spectrum disorders: A large multi-center retrospective study in China. Mult Scler Relat Disord. 2020;1:46.
15.
go back to reference Cacciaguerra L, Meani A, Mesaros S, Radaelli M, Palace J, Dujmovic-Basuroski I, et al. Brain and cord imaging features in neuromyelitis optica spectrum disorders. Ann Neurol. 2019;85(3):371–84.CrossRefPubMed Cacciaguerra L, Meani A, Mesaros S, Radaelli M, Palace J, Dujmovic-Basuroski I, et al. Brain and cord imaging features in neuromyelitis optica spectrum disorders. Ann Neurol. 2019;85(3):371–84.CrossRefPubMed
16.
go back to reference Kim SH, Huh SY, Hyun JW, Jeong IH, Lee SH, Joung AR, et al. A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder. PLoS One. 2014;9(9):e108320.CrossRefPubMedPubMedCentral Kim SH, Huh SY, Hyun JW, Jeong IH, Lee SH, Joung AR, et al. A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder. PLoS One. 2014;9(9):e108320.CrossRefPubMedPubMedCentral
19.
go back to reference Tam RC, Traboulsee A, Riddehough A, Li DKB. Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis. Neuroimage Clin. 2012;1(1):29–36.CrossRefPubMedPubMedCentral Tam RC, Traboulsee A, Riddehough A, Li DKB. Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis. Neuroimage Clin. 2012;1(1):29–36.CrossRefPubMedPubMedCentral
20.
go back to reference Ciccarelli O, Cohen JA, Reingold SC, Weinshenker BG, Amato MP, Banwell B, et al. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. Lancet Neurol. 2019;18(2):185–97.CrossRefPubMed Ciccarelli O, Cohen JA, Reingold SC, Weinshenker BG, Amato MP, Banwell B, et al. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. Lancet Neurol. 2019;18(2):185–97.CrossRefPubMed
21.
go back to reference Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, et al. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015;72(1):81–7.CrossRefPubMedPubMedCentral Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, et al. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015;72(1):81–7.CrossRefPubMedPubMedCentral
22.
go back to reference Cacciaguerra L, Valsasina P, Mesaros S, Martinelli V, Drulovic J, Filippi M, et al. Spinal cord atrophy in neuromyelitis optica spectrum disorders is spatially related to cord lesions and disability. Radiology. 2020;297(1):154–63.CrossRefPubMed Cacciaguerra L, Valsasina P, Mesaros S, Martinelli V, Drulovic J, Filippi M, et al. Spinal cord atrophy in neuromyelitis optica spectrum disorders is spatially related to cord lesions and disability. Radiology. 2020;297(1):154–63.CrossRefPubMed
23.
go back to reference Bonnan M, Debeugny S, Mejdoubi M, Cabre P. Predictive value of conventional MRI parameters in first spinal attacks of neuromyelitis optica spectrum disorder. Mult Scler. 2020;26(4):468–75.CrossRefPubMed Bonnan M, Debeugny S, Mejdoubi M, Cabre P. Predictive value of conventional MRI parameters in first spinal attacks of neuromyelitis optica spectrum disorder. Mult Scler. 2020;26(4):468–75.CrossRefPubMed
24.
go back to reference Mealy MA, Mossburg SE, Kim SH, Messina S, Borisow N, Lopez-Gonzalez R, et al. Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions. Mult Scler Relat Disord. 2019;1(28):64–8.CrossRef Mealy MA, Mossburg SE, Kim SH, Messina S, Borisow N, Lopez-Gonzalez R, et al. Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions. Mult Scler Relat Disord. 2019;1(28):64–8.CrossRef
26.
go back to reference Hsu JL, Liao MF, Chang KH, Cheng MY. Ro LS Correlations among disability antiAQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD. BMC Neurol. 2021;21:1–9.CrossRef Hsu JL, Liao MF, Chang KH, Cheng MY. Ro LS Correlations among disability antiAQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD. BMC Neurol. 2021;21:1–9.CrossRef
Metadata
Title
T1 hypointense brain lesions in NMOSD and its relevance with disability: a single institution cross-sectional study
Authors
Mohamad Ghazanfari Hashemi
Vahid Talebi
Naghmeh Abbasi Kasbi
Mehrshad Abbasi
Nasrin Asgari
Mohammad Ali Sahraian
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03550-1

Other articles of this Issue 1/2024

BMC Neurology 1/2024 Go to the issue